ABSTRACT
Despite intensive international efforts to extend the coverage of primary healthcare services for women, pregnancy and childbirth still represent a high-risk period for both mother and child, particularly in low- and middle-income countries. Lack of access to antenatal care and its inadequate use during pregnancy contribute to maternal mortality. This study aimed to establish the factors associated with late start of antenatal care (ANC) in Muramvya health district, Burundi. A cross– sectional study was carried out in six randomly selected health facilities of the Muramvya district. The study population consisted of pregnant women who attended antenatal clinics. A total of 280 women were included in the study. Data were collected through face-to-face interviews. Descriptive statistics, bivariate and multivariate logistic regression models were used to measure the determinants of the late start of ANC after 12 weeks of gestation. ANC was initiated after 12 weeks of pregnancy in 72.50% of women, 58.6% and 13.9% respectively in the second and last trimester. Based on Multivariate logistic regression: Women between 20 and 35 years of age have a lower risk of starting ANC late than adolescents (AOR = 0.18; 95%CI:0.03-0.83). Lack of knowledge about the interventions offered during ANC (AOR = 2.37; 95%CI:1.32-4.25), late recognition of pregnancy status (AOR= 6.7; 95%CI:2.41-18.66), unplanned pregnancy (AOR = 1.85 95%CI:1.01-3.40) and the time for women to reach the health facility: between 30minutes to 1 hour (AOR = 2.40 95%CI:1.25-4.59) and more than 1 hour of walking (AOR = 2.15; 95%CI:1.01-4.60) are associated with the late start of ANC. The results of the study show that most women start ANC late. There is a need for effective behavioral interventions and public awareness and education targeting adolescents and women to improve early initiation of ANC
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The corresponding author himself used his own ressources to finance this reseach
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The approval was given by The Institution review abroad (INSP) contact: Pr NDIZEYE Judith email: ndayizeyejud{at}yahoo.fr INSP: master.ssp{at}insp.bi web: www.insp.bi
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
Data Availability
Data are available